{"DDN": "25/10/1979", "DateRCP": "18/03/2022", "DatePrelevement": "18/03/2022", "NaturePrelevement": "tumorectomie", "ResiduTumoralApresChirurgie": "X", "T": "T2", "N": "N0", "M": "M0", "Histologie": "carcinome NST pT2 de 23mm, RH+ HER2-, Ki67 60%, embols vasculaires et p\u00e9ri-tumoraux", "MotifRCP": "AjustementTherapeutique", "ATCD": "aucun", "HDM": "patiente de 43 ans non m\u00e9naupos\u00e9e. 2022: cancer du QSI du sein droit NST pT2 de 23mm, RH+ HER2-, Ki67 60%, embols vasculaires et p\u00e9ri-tumoraux. Traitement par tumorectomie, chimioth\u00e9rapie (4EC 12 Taxol), radioth\u00e9rapie. ", "Question": "Choix de l'hormonotherapie: Tamoxifene + Suppression ovarienne ?", "OMS": 1.0, "Decouverte": "DepistageIndividuel", "PhaseMaladie": "PhaseInitiale", "DPD": "NonRealise", "TypeTT": "Hormonoth\u00e9rapie", "DetailTT": "Tamoxifene + Suppression ovarienne (agoniste LHRH)", "PhaseTT": "MiseEnTraitement", "TypeTT2": null, "TypeTT3": null}
